NEWSROOM
Press Releases by Agendia
News
Press Releases
RASTER: First-Ever Prospective Diagnostic Study in Breast Cancer
RASTER Five-Year Follow-Up Data Indicates Chemotherapy May Be Safely Withheld for Patients Deemed โLow Riskโ for Breast Cancer Recurrence Using Agendiaโs MammaPrint Test, Data Presented at European Breast Cancer Conference IRVINE, CA and AMSTERDAM, THE Read More
Agendia Wins 2011 Scrip Award for โBest Partnership Allianceโ
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, FEBRUARY 29, 2012 โ Agendia, an innovative molecular cancer diagnostics company, today announced that the company is a recipient of the 2011 Scrip Award for โBest Partnershipโ for its Read More
Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual Meeting
HUNTINGTON BEACH, CA, and AMSTERDAM, THE NETHERLANDS, June 4, 2010ย -- Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present Read More
Agendia to Present at BioCentury’s Future Leaders in the Biotech Industry Conference
HUNTINGTON BEACH, CA, and AMSTERDAM, THE NETHERLANDS, March 24, 2009 -- Agendia, a world leader in molecular cancer diagnostics, today announced that the Company is scheduled to present at the 16th Anniversary "Future Leaders in Read More